Pharma & Biotech News #PharmaBuzz

Market Place

Sourcing Support

Weekly News Recap #Phispers

J&J plans US$ 55 bn investment in US to avoid Trump's tariffs; Astra to invest US$ 2.5 bn in Chinese R&D centre

This week’s Phispers brings you lots of news from China. AstraZeneca is investing US$ 2.5 billion in a new Beijing resear...

Impressions : 713

Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

In Phispers this week, two drugmakers emerging from bankruptcy — Mallinckrodt and Endo — are merging in order to le...

Impressions : 1041

Roche buys rights to Zealand's obesity med in US$ 5.3 bn deal; Merck wins Gardasil lawsuit, bolsters vaccine manufacturing

In news this week, Roche has acquired rights to develop and commercialize Zealand Pharma’s experimental obesity drug petr...

Impressions : 1124

AbbVie enters obesity race with US$ 2.23 bn deal with Denmark's Gubra; Roche's TNKase approved for treating strokes

AbbVie has forayed into the obesity treatment market with a US$ 2.23 billion licensing deal with Denmark’s Gubra for its ...

Impressions : 829

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

J&J plans US$ 55 bn investment in US to avoid Trump's tariffs; Astra to invest US$ 2.5 bn in Chinese R&D centre

Mallinckrodt, Endo merge in US$ 6.7 bn deal; Astra buys cell therapy developer EsoBiotec; Pfizer sells entire stake in Haleon

Roche buys rights to Zealand's obesity med in US$ 5.3 bn deal; Merck wins Gardasil lawsuit, bolsters vaccine manufacturing

AbbVie enters obesity race with US$ 2.23 bn deal with Denmark's Gubra; Roche's TNKase approved for treating strokes

Fresenius Kabi's Biologic Bomyntra Receives Approval in US

Fresenius Kabi's Biologic Conexxence Receives Approval in US

Fresenius Kabi's Biologic Denosumab Receives Approval in US

AMTA's Generics Diltiazem HCl Receives Approval in US

Merck's Biologic Keytruda Receives Approval in US

Biogen's Biologic Tysabri Receives Suppl Approval in US

Sandoz's Biologic Imuldosa Receives Suppl Approval in US

Taro's Generics Rivaroxaban Receives Tentative Approval in US

Taro's Generics Rivaroxaban Receives Approval in US

Lupin's Generics Rivaroxaban Receives Approval in US

Enforcement Report - Week of March 26, 2025

Enforcement Report - Week of March 19, 2025

Yung Shin Pharma is on Health Canada Inspection List

Tyche Industries is on Health Canada Inspection List

Nectar Lifesciences is on Health Canada Inspection List

Mylan Labs is on Health Canada Inspection List

Jagsonpal Pharmaceuticals is on Health Canada Inspection List

Indoco Remedies Limited is on Health Canada Inspection List

Global Calcium is on Health Canada Inspection List

Genzyme Corporation is on Health Canada Inspection List

Novartis receives FDA accelerated approval for Vanrafia

FDA misses deadline for decision on Novavax's vaccine

Marubeni grabs Sumitomo's Asia pharma business in $480M deal

Indian pharma stocks 'breathe easy' on US tariffs exemption

Novo nearly doubles earnings as Wegovy swells coffers

Roche's high-dose version of Ocrevus flunks phase 3 trial

FDA taps insider Scott Steele to lead CBER on acting basis

Public health group sue over $1.1B in revoked funds

Sanofi pays Nurix $15M upfront for autoimmune degrader

Curium's Generic DTPA - Kit for Technetium Tc 99m Approved in US

Curium's Generic DTPA - Kit for Technetium Tc 99m Approved in US

Glenmark Pharma launches Vancomycin HCl for injection in US

Akums launches Ripasudil + Timolol combo for glaucoma

Singleton Schreiber Leads Effort for Women Affected by Depo-Provera

Nexus Pharmaceuticals Launches Fluorescein 2 mL

Teva's Schizophrenia Portfolio Enhanced by Ph 3 Trial Results

Aveva Drug Delivery (A DifGen company) gets FDA nod for Lidocaine

Cadila Launches Cadilose For Constipation, Hepatic Encephalopathy

Journey Medical Launches Emrosi™ for Rosacea Treatment

Brazil's Hypera to launch an Ozempic generic in 2026

FDA misses deadline for decision on Novavax's vaccine

Roche's high-dose version of Ocrevus flunks phase 3 trial

Sanofi pays Nurix $15M upfront for autoimmune degrader

Pfizer, Flagship turn to autoimmune for latest angle of collab

Europe approves Pfizer's RSV vaccine for adults at increased risk

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Tovecimig (CTX-009) Meets Primary Endpoint in Biliary Tract Cance

SynOx Therapeutics Announces Board Chair Transition for Strategy

Celcuity to Present at Needham and Stifel Investor Conferences

Revive Therapeutics Acquires Molecular Hydrogen Program

2024 Universal Registration Document with Annual Financial Report

Esteve Química Win 2025 CDMO Leadership Award, Plans U.S. Expansion

Quotient's completes $1.4 M project to Improve HPAPI

Shilpa Wins SEC-CDSCO Nod For Nor-Ursodeoxycholic Acid In NASH

LGM Pharma Invests $6M in U.S. Drug Manufacturing Capabilities

The Noramco Invests $25M into Halo Pharma Facility in NJ

Axplora Launches Payload Manufacturing Workshop in France

Leader in CADIFA approval

HighByte Launches API Builder for Industrial Data

Senores Pharma begins operations at greenfield API facility

Public health group sue over $1.1B in revoked funds

FDA finds data integrity problems in recent warning letters

47 drugs found 'not of standard quality' in February

Bausch + Lomb recalls some of its implantable eye lenses

NY official rejects Texas judgment against doctor in abortion pill case

PCI warns inspectors not following guidelines of tough action

AICDF alleges counterfeit drugs reaching WB via local trains

Delhi HC tells Natco Pharma to halt Risdiplam launch

Ractigen's RAG-01 Shows Complete Responses in Ph I NMIBC Trail

Carbogen Amcis Secures GMP Certification After ANSM Inspection

ATMOS gets FDA clearance for Cardiothoracic Digital Drain

GE HealthCare, FPT Expand Partnership for AI Healthcare Innovation

Attralus Presents Data on Pan-Amyloid Diagnostics at ACC Session